The association between NAFLD and risk of chronic kidney disease: a cross-sectional study

Objective: The aim of this study was to evaluate the association between nonalcoholic fatty liver disease (NAFLD) and NAFLD with different comorbidities and risk of chronic kidney disease (CKD) and abnormal albuminuria. Materials and Methods: A total of 3872 Chinese individuals excluding those with...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ying Cao, You Deng, Jingjing Wang, Hong Zhao, Jingyu Zhang, Wen Xie
Formato: article
Lenguaje:EN
Publicado: SAGE Publishing 2021
Materias:
Acceso en línea:https://doaj.org/article/39e9065d1081459eb92192b66e7838fa
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:39e9065d1081459eb92192b66e7838fa
record_format dspace
spelling oai:doaj.org-article:39e9065d1081459eb92192b66e7838fa2021-11-10T23:03:29ZThe association between NAFLD and risk of chronic kidney disease: a cross-sectional study2040-623110.1177/20406223211048649https://doaj.org/article/39e9065d1081459eb92192b66e7838fa2021-11-01T00:00:00Zhttps://doi.org/10.1177/20406223211048649https://doaj.org/toc/2040-6231Objective: The aim of this study was to evaluate the association between nonalcoholic fatty liver disease (NAFLD) and NAFLD with different comorbidities and risk of chronic kidney disease (CKD) and abnormal albuminuria. Materials and Methods: A total of 3872 Chinese individuals excluding those with hepatitis B or C infection and absence of alcohol abuse were included in the study. NAFLD was diagnosed by abdominal ultrasonography. The liver fibrosis was assessed by NAFLD fibrosis score (NFS) and fibrosis-4 index (FIB-4). CKD was defined as an estimated glomerular filtration rate (eGFR) < 60 ml/min/1.73 m 2 and/or abnormal albuminuria (urinary albumin-to-creatinine ratio ⩾ 3 mg/mmol). The logistic regression analysis was performed to examine the association between NAFLD and NAFLD with different comorbidities and risk of CKD. Results: The prevalence of CKD and abnormal albuminuria was higher in individuals with NAFLD than in those without NAFLD (15.8% vs 11.9%, p  < 0.001; 14.8% vs 11.0%, p  < 0.001). Logistic regression analysis demonstrated that NAFLD was risk factor of CKD. Notably, after adjustment for sex, age, and DM, NAFLD was associated with 1.31-fold higher risk of prevalent CKD ⩾ 1 ( p  < 0.05). NAFLD individuals with elder age, DM, obesity, hypertension, MetS, and advanced liver fibrosis had higher risks of both prevalent CKD and abnormal albuminuria than those without comorbidities. Conclusions: NAFLD and NAFLD with traditional comorbidities are strongly associated with risk of prevalence of CKD and abnormal albuminuria. Patients with NAFLD especially those with coexisting comorbidities were recommended to carefully access the development of CKD.Ying CaoYou DengJingjing WangHong ZhaoJingyu ZhangWen XieSAGE PublishingarticleTherapeutics. PharmacologyRM1-950ENTherapeutic Advances in Chronic Disease, Vol 12 (2021)
institution DOAJ
collection DOAJ
language EN
topic Therapeutics. Pharmacology
RM1-950
spellingShingle Therapeutics. Pharmacology
RM1-950
Ying Cao
You Deng
Jingjing Wang
Hong Zhao
Jingyu Zhang
Wen Xie
The association between NAFLD and risk of chronic kidney disease: a cross-sectional study
description Objective: The aim of this study was to evaluate the association between nonalcoholic fatty liver disease (NAFLD) and NAFLD with different comorbidities and risk of chronic kidney disease (CKD) and abnormal albuminuria. Materials and Methods: A total of 3872 Chinese individuals excluding those with hepatitis B or C infection and absence of alcohol abuse were included in the study. NAFLD was diagnosed by abdominal ultrasonography. The liver fibrosis was assessed by NAFLD fibrosis score (NFS) and fibrosis-4 index (FIB-4). CKD was defined as an estimated glomerular filtration rate (eGFR) < 60 ml/min/1.73 m 2 and/or abnormal albuminuria (urinary albumin-to-creatinine ratio ⩾ 3 mg/mmol). The logistic regression analysis was performed to examine the association between NAFLD and NAFLD with different comorbidities and risk of CKD. Results: The prevalence of CKD and abnormal albuminuria was higher in individuals with NAFLD than in those without NAFLD (15.8% vs 11.9%, p  < 0.001; 14.8% vs 11.0%, p  < 0.001). Logistic regression analysis demonstrated that NAFLD was risk factor of CKD. Notably, after adjustment for sex, age, and DM, NAFLD was associated with 1.31-fold higher risk of prevalent CKD ⩾ 1 ( p  < 0.05). NAFLD individuals with elder age, DM, obesity, hypertension, MetS, and advanced liver fibrosis had higher risks of both prevalent CKD and abnormal albuminuria than those without comorbidities. Conclusions: NAFLD and NAFLD with traditional comorbidities are strongly associated with risk of prevalence of CKD and abnormal albuminuria. Patients with NAFLD especially those with coexisting comorbidities were recommended to carefully access the development of CKD.
format article
author Ying Cao
You Deng
Jingjing Wang
Hong Zhao
Jingyu Zhang
Wen Xie
author_facet Ying Cao
You Deng
Jingjing Wang
Hong Zhao
Jingyu Zhang
Wen Xie
author_sort Ying Cao
title The association between NAFLD and risk of chronic kidney disease: a cross-sectional study
title_short The association between NAFLD and risk of chronic kidney disease: a cross-sectional study
title_full The association between NAFLD and risk of chronic kidney disease: a cross-sectional study
title_fullStr The association between NAFLD and risk of chronic kidney disease: a cross-sectional study
title_full_unstemmed The association between NAFLD and risk of chronic kidney disease: a cross-sectional study
title_sort association between nafld and risk of chronic kidney disease: a cross-sectional study
publisher SAGE Publishing
publishDate 2021
url https://doaj.org/article/39e9065d1081459eb92192b66e7838fa
work_keys_str_mv AT yingcao theassociationbetweennafldandriskofchronickidneydiseaseacrosssectionalstudy
AT youdeng theassociationbetweennafldandriskofchronickidneydiseaseacrosssectionalstudy
AT jingjingwang theassociationbetweennafldandriskofchronickidneydiseaseacrosssectionalstudy
AT hongzhao theassociationbetweennafldandriskofchronickidneydiseaseacrosssectionalstudy
AT jingyuzhang theassociationbetweennafldandriskofchronickidneydiseaseacrosssectionalstudy
AT wenxie theassociationbetweennafldandriskofchronickidneydiseaseacrosssectionalstudy
AT yingcao associationbetweennafldandriskofchronickidneydiseaseacrosssectionalstudy
AT youdeng associationbetweennafldandriskofchronickidneydiseaseacrosssectionalstudy
AT jingjingwang associationbetweennafldandriskofchronickidneydiseaseacrosssectionalstudy
AT hongzhao associationbetweennafldandriskofchronickidneydiseaseacrosssectionalstudy
AT jingyuzhang associationbetweennafldandriskofchronickidneydiseaseacrosssectionalstudy
AT wenxie associationbetweennafldandriskofchronickidneydiseaseacrosssectionalstudy
_version_ 1718439661094830080